Tenon Medical Q3 revenue rises as procedure volume grows
TNON•Tenon Medical’s Q3 revenue rose 22% year over year to $1.43 million, while its net loss widened to $6.64 million. The company raised $15.6 million, repaid convertible notes and ended the quarter with no debt.
1. Revenue and loss
Tenon Medical said Q3 revenue rose 22% year over year to $1.43 million, primarily driven by increased surgical procedure volume, including continued adoption of its SImmetry+ System. Net loss was $6.64 million, with non-cash warrant and interest expenses contributing to the widening loss.
2. Products and outlook
Gross margin improved as higher revenue absorbed fixed costs and Catamaran per-procedure costs improved after 510(k) clearance for reusable instruments. The company said it is targeting a full market release of its Quickstep Decorticator in Q1 2027 and plans to expand its commercial organization through hiring and distributor partnerships.
